JPS6049635B2 - 2-phenyl-4H-1,3-thiazine derivative and method for producing the same - Google Patents

2-phenyl-4H-1,3-thiazine derivative and method for producing the same

Info

Publication number
JPS6049635B2
JPS6049635B2 JP2543977A JP2543977A JPS6049635B2 JP S6049635 B2 JPS6049635 B2 JP S6049635B2 JP 2543977 A JP2543977 A JP 2543977A JP 2543977 A JP2543977 A JP 2543977A JP S6049635 B2 JPS6049635 B2 JP S6049635B2
Authority
JP
Japan
Prior art keywords
formula
tables
formulas
general formula
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP2543977A
Other languages
Japanese (ja)
Other versions
JPS53111080A (en
Inventor
匡男 平山
俊三 深津
誠夫 関
仁 五井
雄次郎 山田
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Meiji Seika Kaisha Ltd
Original Assignee
Meiji Seika Kaisha Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Meiji Seika Kaisha Ltd filed Critical Meiji Seika Kaisha Ltd
Priority to JP2543977A priority Critical patent/JPS6049635B2/en
Publication of JPS53111080A publication Critical patent/JPS53111080A/en
Publication of JPS6049635B2 publication Critical patent/JPS6049635B2/en
Expired legal-status Critical Current

Links

Landscapes

  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Description

【発明の詳細な説明】 本発明は新規な2−フェニルー4H−1,3−チアジン
誘導体、及びかかる誘導体の製造法に関するものである
DETAILED DESCRIPTION OF THE INVENTION The present invention relates to novel 2-phenyl-4H-1,3-thiazine derivatives and methods for producing such derivatives.

すなわち、本発明第1のは一般式〔1〕 (式中、Zは次式: の基を表わし、R.sRl、R2およびR3は同一でも
異なつてもよく、水素または炭素数1〜2のアルキル基
を示す)で表わされる2−フェニルー胆−1,3−チア
ジン誘導体を提供する。
That is, the first aspect of the present invention represents a group of the general formula [1] (wherein Z represents the following formula: R.sRl, R2 and R3 may be the same or different, and represent hydrogen or a group having 1 to 2 carbon atoms. The present invention provides a 2-phenyl-bi-1,3-thiazine derivative represented by the formula (indicating an alkyl group).

従来、4H−1,3−チアジン類を製造する方法は幾通
りか報告されているが、5位にカルボキシル基またはそ
のエステル基を有する4H−1,3−チアジン類を製造
する方法は未だ報告されていない。
Conventionally, several methods for producing 4H-1,3-thiazines have been reported, but no method for producing 4H-1,3-thiazines having a carboxyl group or its ester group at the 5-position has yet been reported. It has not been.

本発明の方法によれば、一般式〔1〕の化合物は、一般
式〔■〕(式中、R,、R2およびR3は前記の意義を
有し、R″は炭素数1〜2のアルキル基を示す)の化合
物を五硫化燐と反応させて前記一般式〔1〕における基
Z(7)Rが炭素数1〜2のアルキル基を表わす化合物
を得、所望ならばこの化合物を加水分解してRが水素を
表わす一般式〔1〕の対応化合物を得ることによつて製
造できる。
According to the method of the present invention, the compound of the general formula [1] is a compound of the general formula [■] (wherein R,, R2 and R3 have the above-mentioned meanings, and R'' is an alkyl group having 1 to 2 carbon atoms. A compound in which the group Z(7)R in the general formula [1] represents an alkyl group having 1 to 2 carbon atoms is obtained by reacting the compound (representing a group) with phosphorus pentasulfide, and if desired, this compound is hydrolyzed. It can be produced by obtaining a corresponding compound of general formula [1] in which R represents hydrogen.

詳しく言えば、第2の本発明によれば、一般式〔■〕(
式中、R1、R2およびR3は同一でも異なつてもよく
、水素または炭素数1〜2のアルキル基を示し、R″は
炭素数1〜2のアルキル基を示す)で表わされるα−ベ
ンズアミドメチルーβ−ケト酸エステルに五硫化燐を作
用させることを特徴とする、一般式〔1″〕(式中、Z
″は次式: の基を表わし、R″R1、R2およびR3は前記と同じ
意義を有する)で表わされる2−フェニルー4−H−1
,3−チアジン誘導体の製造法が提供される。
Specifically, according to the second invention, the general formula [■] (
In the formula, R1, R2 and R3 may be the same or different and represent hydrogen or an alkyl group having 1 to 2 carbon atoms, and R'' represents an alkyl group having 1 to 2 carbon atoms. General formula [1''] (in the formula, Z
"represents a group of the following formula: 2-phenyl-4-H-1 represented by R" R1, R2 and R3 have the same meanings as above)
, 3-thiazine derivatives are provided.

また、第3の本発明によれば、一般式〔旧(式中、R1
、R2およびR3は同一でも異なつてもよく、水素また
は炭素数1〜2のアルキル基を示し、R″は炭素数1〜
2のアルキル基を示す)で表わされるα−ベンズアミド
メチルーβ−ケト酸エステルに五硫化燐を作用させて一
般式〔1″] (式中、Z″は次式: の基を表わし、R″R1、R2およびR3は前記と同じ
意義を有する)の化合物を生成させ、ついでこの化合物
を加水分解して上記一般式〔■″〕における基z″のR
″が水素である対応化合物を得ることを特徴とする2−
フェニルー刑−1,3−チアジン誘導体の製造法が提供
される。
Further, according to the third aspect of the present invention, the general formula [old (formula, R1
, R2 and R3 may be the same or different and represent hydrogen or an alkyl group having 1 to 2 carbon atoms, and R'' is an alkyl group having 1 to 2 carbon atoms.
The α-benzamidomethyl-β-keto acid ester represented by the alkyl group of 2) is reacted with phosphorus pentasulfide to form a compound of the general formula [1″] (where Z″ represents a group of the following formula: "R1, R2 and R3 have the same meanings as above)", and then this compound is hydrolyzed to form R of the group z" in the general formula [■"]
2-, characterized in that a corresponding compound is obtained in which ″ is hydrogen;
A method for producing a phenyl-1,3-thiazine derivative is provided.

式〔旧の化合物と五硫化燐との反応は通常ベンゼン、ト
ルエン、キシレン、エチルエーテル等の如き適当な有機
溶剤中で実施され、好ましくは溶剤の還流温度で行なわ
れる。
The reaction of the former compound with phosphorus pentasulfide is usually carried out in a suitable organic solvent such as benzene, toluene, xylene, ethyl ether, etc., preferably at the reflux temperature of the solvent.

式(1)の化合物の基Z中のRが炭素数1〜2のアルキ
ル基を表わす場合の化合物、すなわち第3の本発明の方
法での中間体化合物〔1″〕の加水分解は通常水酸化ナ
トリウム、水酸化カリウム、炭酸ナトリウム、炭酸カリ
ウム等の如き塩基の存在下で、例えば水、含水メタノー
ル、含水エタノール等の溶剤を用いて実施できる。
In the case where R in the group Z of the compound of formula (1) represents an alkyl group having 1 to 2 carbon atoms, the intermediate compound [1''] in the method of the third invention is usually hydrolyzed with water. This can be carried out in the presence of a base such as sodium oxide, potassium hydroxide, sodium carbonate, potassium carbonate, etc., using a solvent such as water, aqueous methanol, or aqueous ethanol.

原料として使用される一般式〔■〕の化合物はChem
.Ber.、?、1599(1959)に記載される公
知の方法により製造できる。
The compound of general formula [■] used as a raw material is Chem
.. Ber. ,? , 1599 (1959).

本発明による一般式〔1〕の化合物は興味ある薬理作用
、特に顕著な鎮痙作用を示すので医薬として有用である
The compounds of general formula [1] according to the present invention exhibit interesting pharmacological effects, particularly remarkable antispasmodic effects, and are therefore useful as medicines.

次に本発明を実施例により更に説明するが、こ)れら実
施例は本発明を何ら限定するものではない。
Next, the present invention will be further explained with reference to Examples, but these Examples are not intended to limit the present invention in any way.

実施例1 2−フェニルー6メチルー化−1,3−チアジンー5−
カルボン酸エチルおよび2−フエニタ ルー6−メチレ
ンー5,6−ジヒドロー心一1,3−チアジンー5−カ
ルボン酸エチル乾燥トルエン(200m1)に溶解した
2−ベンズアミドメチルアセト酢酸エチル(13.15
mg、50ミリモル)を乾燥トルエン(100m1)中
の五硫化燐θ(6.5y)懸濁液に還流攪拌下で3時間
かけて滴下した。
Example 1 2-phenyl-6methylated-1,3-thiazine-5-
Ethyl carboxylate and 2-phenylene-6-methylene-5,6-dihydro-1,3-thiazine-5-carboxylate Ethyl 2-benzamidomethylacetoacetate (13.15 ml) dissolved in dry toluene (200 ml)
mg, 50 mmol) was added dropwise to a suspension of phosphorus pentasulfide θ(6.5y) in dry toluene (100 ml) over 3 hours under reflux stirring.

この混合物を4時間攪拌して冷却後、10%水酸化ナト
リウム水溶液(200m1)およびエーテル(100m
1)を加えて激しく攪拌して析出している固体を溶解さ
せた。生じた有機層を分離した5後、水層をエーテル抽
出し、抽出液を有機層と一緒にした。この有機層を1N
塩酸(50mL×5)で抽出し、更にへ塩酸で同様に抽
出した。1N塩酸抽出液を10%水酸化ナトリウム水溶
液によりPHl2とし、エーテル抽出した。
The mixture was stirred for 4 hours and cooled, followed by a 10% aqueous sodium hydroxide solution (200 ml) and ether (100 ml).
1) was added and stirred vigorously to dissolve the precipitated solid. After separating the resulting organic layer, the aqueous layer was extracted with ether and the extracts were combined with the organic layer. This organic layer was heated to 1N
The mixture was extracted with hydrochloric acid (50 mL x 5), and further extracted in the same manner with hydrochloric acid. The 1N hydrochloric acid extract was adjusted to PHL2 with a 10% aqueous sodium hydroxide solution and extracted with ether.

エーテル層FOを水洗し、乾燥した後溶媒を除去すると
ほぼ純粋の2−フェニルー6−メチレンー5,6−ジヒ
ドロー4H−1,3−チアジンー5−カルボン酸エチル
1.614g(12.4%)を得た。更にこの生成物を
減圧蒸留して純品を得た。Bpl4O−142℃/0.
2Tf$LHgO元素分析(Cl4Hl5NO2S) 計算値:C%64.3表H%5.7gsN%5.36実
測値:C%63.99sH%6.1屯N%5.13へ塩
酸抽出液を同様に処理すると黄色油状物1.035yが
得られた。
After washing the ether layer FO with water and removing the solvent after drying, 1.614 g (12.4%) of almost pure ethyl 2-phenyl-6-methylene-5,6-dihydro-4H-1,3-thiazine-5-carboxylate was obtained. Obtained. Further, this product was distilled under reduced pressure to obtain a pure product. Bpl4O-142℃/0.
2Tf$LHgO elemental analysis (Cl4Hl5NO2S) Calculated value: C%64.3 Table H%5.7gsN%5.36 Actual value: C%63.99sH%6.1 TonN%5.13 Add the hydrochloric acid extract in the same manner 1.035y of yellow oil was obtained.

NMRスペクトルによりこの油状物は2−フェニルー6
−メチルー心−1,3−チアジンー5−カルボン酸エチ
ルと2−フェニルー6−メチレンー5,6−ジヒドロー
4H一1,3−チアジンー5−カルボン酸エチルの混合
物であり、その比は66:34であることが確認された
。この油状物質をシリカゲルクロマトグラフィーにより
分離(溶離液、2%酢酸エチル−ベンゼン)してそれぞ
れの純品を得た。得られた2−フェニルー6−メチルー
4H−1,3−チアジンー5−カルボン酸エチルの物性
は次の通りである。Bpl38−140ルC/0.4T
!$THg元素分析(Cl4Hl5NO2S)計算値:
C%64.34、H%5.7宋N%5.36実測値:C
%64.22、H%5.絽、N%5.3L実施例22−
フェニルー5−エチルー6−メチレンー5,6−ジヒド
ロー止−1,3−チアジンー5−カルボン酸エチル2−
ベンズアミドメチルー2−エチルアセト酢2酸エチル(
40y)および五硫化燐(12.0q)を用いて実施例
1と同様に反応を行ない、後処理において塩酸による抽
出をへ塩酸のみで行ない、以下実施例1と同様に処理す
ると油状物11.379を得た。
The NMR spectrum reveals that this oil is 2-phenyl-6
It is a mixture of ethyl-methyl-1,3-thiazine-5-carboxylate and ethyl 2-phenyl-6-methylene-5,6-dihydro-4H-1,3-thiazine-5-carboxylate in a ratio of 66:34. It was confirmed that there is. This oily substance was separated by silica gel chromatography (eluent: 2% ethyl acetate-benzene) to obtain each pure product. The physical properties of the obtained ethyl 2-phenyl-6-methyl-4H-1,3-thiazine-5-carboxylate are as follows. Bpl38-140ruC/0.4T
! $THg elemental analysis (Cl4Hl5NO2S) calculated value:
C%64.34, H%5.7 Song N%5.36 Actual value: C
%64.22, H%5. Silk, N% 5.3L Example 22-
phenyl-5-ethyl-6-methylene-5,6-dihydro-1,3-thiazine-5-ethyl carboxylate 2-
Ethyl benzamidomethyl-2-ethylacetoacetate (
40y) and phosphorus pentasulfide (12.0q) in the same manner as in Example 1, and in the post-treatment, extraction with hydrochloric acid was performed with only hydrochloric acid, and the following treatment was carried out in the same manner as in Example 1 to obtain an oily substance 11. I got 379.

更に減圧蒸留を行うと標記化合物8.755y3(22
.6%)を得た。Bpl52−155℃/0.2?Hg
元素分析(Cl6Hl9NO2S)計算値:C%66.
40、H%6.62、N%4.84実測値:C%66泪
、H%6.61、N%4.93また2−ベンズアミドメ
チルー2−エチルアセ3j卜酢酸エチルの代りに次表に
示したR1、R2、R3、R″(R)の置換基を有する
化合物を使用し、実施例2と同様の操作を行つて同表に
示される生成物〔1〕を得た。
Further vacuum distillation yields the title compound 8.755y3(22
.. 6%). Bpl52-155℃/0.2? Hg
Elemental analysis (Cl6Hl9NO2S) calculated value: C%66.
40, H% 6.62, N% 4.84 Actual values: C% 66, H% 6.61, N% 4.93 Also, in place of 2-benzamidomethyl-2-ethyl acetate, the following table Using a compound having substituents R1, R2, R3, and R'' (R) shown in Table 1, the same operations as in Example 2 were carried out to obtain product [1] shown in the same table.

4C実
施例772−フェニルー6−メチルー■−1,3−チア
ジンー5−カルボン酸2−フェニルー6−メチルー倶−
1,3−チアジンー5−カルボン酸エチル(1.837
y)、0.5N水酸化ナトリウム水溶液(15.4m1
)およびエタノール(35m1)の混合物を室温にて4
時間攪拌した。
4C Example 77 2-Phenyl-6-methyl-1,3-thiazine-5-carboxylic acid 2-phenyl-6-methyl-
Ethyl 1,3-thiazine-5-carboxylate (1.837
y), 0.5N aqueous sodium hydroxide solution (15.4ml
) and ethanol (35ml) at room temperature.
Stir for hours.

ついでエタノールを留去後、残渣を水(30m1)で希
釈し、エーテル抽出した。水層を1N塩酸にてPH3.
Oとした後クロロホルム抽出し、クロロホルム層を水洗
、乾燥後濃縮して標記化合物1.327V(81.3%
)を得た。Mpl4O−141℃元素分析(Cl2Hl
lNO2S)計算値:C%61.78F.H%4.7飄
N%6.00実測値:C%61.52、H%4.8へN
%5.83実施例8本例は本発明による化合物の鎮痙作
用について説明するものである。
After ethanol was then distilled off, the residue was diluted with water (30ml) and extracted with ether. The aqueous layer was adjusted to pH3 with 1N hydrochloric acid.
The chloroform layer was washed with water, dried and concentrated to give the title compound 1.327V (81.3%).
) was obtained. Mpl4O-141℃ elemental analysis (Cl2Hl
lNO2S) Calculated value: C%61.78F. H%4.7 to N%6.00 Actual value: C%61.52, H%4.8 to N
%5.83 Example 8 This example illustrates the antispasmodic action of compounds according to the invention.

本発明による化合物の平滑筋痙れんに対する抑制作用を
、ラットの子宮筋及び回腸を用いたマグヌス法による試
験管内試験によつて測定した。
The inhibitory effect of the compounds according to the invention on smooth muscle spasm was determined by an in vitro test using the uterine muscle and ileum of rats according to the Magnus method.

試験は、組織培養液中に下記の筋収縮剤を入れ、この中
に供試筋を吊して収縮させ、しかる後下記の供試薬剤(
本発明の化合物及び対照化合物)を培養液に添加するこ
とによつて行なつた。〜 筋収縮剤:ブラジキニン(B
K)、アセチルコリン(Ach)、ヒスタミン(HT)
、セロトニン(5−HT)、塩化バリウム(BaCl。
In the test, the following muscle contracting agent is placed in a tissue culture medium, the test muscle is suspended in the tissue culture medium to contract, and then the following test agent (
This was carried out by adding the compounds of the present invention and control compounds) to the culture medium. ~ Muscle contracting agent: bradykinin (B
K), acetylcholine (Ach), histamine (HT)
, serotonin (5-HT), barium chloride (BaCl.

)B)供試薬剤:本発明の化合物一実施例1(2−フェ
ニルー6−メチレンー5,6−ジヒドロー囮−1,3−
チアジンー5−カルボン酸エチル)、実施例3及び5の
化合物; 対照化合物−パパベリン、アンジニン、ホモク
ロミン、アトロピン。
) B) Test drug: Compound of the present invention Example 1 (2-phenyl-6-methylene-5,6-dihydro decoy-1,3-
ethyl thiazine-5-carboxylate), compounds of Examples 3 and 5; control compounds - papaverine, anginine, homoc
Romine, atropine.

試験結果を各供試化合物の50%拮抗濃度(筋の収縮を
50%弛緩させるに要する濃度)の値(Pylml、但
し、*印を付した数字はNflml)によ*)下記の表
に示す。
The test results are shown in the table below according to the 50% antagonistic concentration (concentration required to relax muscle contraction by 50%) of each test compound (Pylml, however, numbers marked with * are Nflml*). .

以上の結果から次のことが認められる。From the above results, the following is recognized.

(1)実施例1、3、5の化合物はいずれも顕著な鎮痙
作用を示し、その作用は向筋肉性鎮痙薬と1して代表さ
れるパパベリンより優れている。
(1) The compounds of Examples 1, 3, and 5 all exhibit significant antispasmodic activity, and this activity is superior to that of papaverine, which is a pro-muscular antispasmodic drug and is represented by 1.

(2)いずれもBaCI2の筋収縮に対してほとんど作
用のないことから筋弛緩作用ではなく、それぞれに特異
的な作用と認められる。(3)実施例5の化合物の払追
K作用は、対照薬剤2のアンジニンに比較して、試管内
ではかなり優れている。
(2) Since both have almost no effect on the muscle contraction of BaCI2, it is recognized that these are not muscle relaxing effects, but rather specific effects for each. (3) The repelling K effect of the compound of Example 5 is considerably superior to that of control drug 2, unginine, in a test tube.

Claims (1)

【特許請求の範囲】 1 一般式〔 I 〕: ▲数式、化学式、表等があります▼〔 I 〕(式中、Z
は次式: ▲数式、化学式、表等があります▼または▲数式、化学
式、表等があります▼の基を表わし、R、R_1、R_
2およびR_3は同一でも異なつてもよく、水素または
炭素数1〜2のアルキル基を示す)で表わされる2−フ
エニル−4H−1,3−チアジン誘導体。 2 一般式〔II〕: ▲数式、化学式、表等があります▼〔II〕(式中、R_
1、R_2およびR_3は同一でも異なってもよく、水
素または炭素数1〜2のアルキル基を示し、R′は炭素
数1〜2のアルキル基を示す)で表わされるα−ベンズ
アミドメチル−β−ケト酸エステルに五硫化燐を作用さ
せることを特徴とする、一般式〔 I ′〕:▲数式、化
学式、表等があります▼〔 I ′〕(式中、Z′は次式
: ▲数式、化学式、表等があります▼または▲数式、化学
式、表等があります▼の基を表わし、R′R^1、R_
2およびR_3は前記と同じ意義を有する)で表わされ
る2−フエニル−4H−1,3−チアジン誘導体の製造
法。 3 一般式〔II〕: ▲数式、化学式、表等があります▼〔II〕〔式中、R_
1、R_2およびR_3は同一でも異なつてもよく、水
素または炭素数1〜2のアルキル基を示し、R′は炭素
数1〜2のアルキル基を示す)で表わされるα−ベンズ
アミドメチル−β−ケト酸エステルに五硫化燐を作用さ
せて一般式〔 I ′〕: ▲数式、化学式、表等があります▼〔 I ′〕(式中、
Z′は次式: ▲数式、化学式、表等があります▼または▲数式、化学
式、表等があります▼の基を表わし、R′R^1、R_
2およびR_3は前記と同じ意義を有する)の化合物を
生成させ、ついでこの化合物を加水分解して上記一般式
〔 I ′〕における基Z′のR′が水素である対応化合
物を得ることを特徴とする2−フエニル−4H−1,3
−チアジン誘導体の製造法。
[Claims] 1. General formula [I]: ▲There are mathematical formulas, chemical formulas, tables, etc.▼[I] (in the formula, Z
represents the group R, R_1, R_
2 and R_3 may be the same or different and represent hydrogen or an alkyl group having 1 to 2 carbon atoms. 2 General formula [II]: ▲There are mathematical formulas, chemical formulas, tables, etc.▼[II] (In the formula, R_
1, R_2 and R_3 may be the same or different and represent hydrogen or an alkyl group having 1 to 2 carbon atoms, and R' represents an alkyl group having 1 to 2 carbon atoms) The general formula [I ′] is characterized by the action of phosphorus pentasulfide on a keto acid ester: ▲ There are mathematical formulas, chemical formulas, tables, etc. ▼ [ I ′] (In the formula, Z′ is the following formula: ▲ Mathematical formula, Chemical formulas, tables, etc. are available ▼ or ▲ Numerical formulas, chemical formulas, tables, etc. are available ▼ represents the group R'R^1, R_
2 and R_3 have the same meanings as above). 3 General formula [II]: ▲ There are mathematical formulas, chemical formulas, tables, etc. ▼ [II] [In the formula, R_
1, R_2 and R_3 may be the same or different and represent hydrogen or an alkyl group having 1 to 2 carbon atoms, and R' represents an alkyl group having 1 to 2 carbon atoms) By reacting phosphorus pentasulfide with a keto acid ester, the general formula [I ′]: ▲There are mathematical formulas, chemical formulas, tables, etc.▼[I ′] (in the formula,
Z' represents the group of the following formula: ▲There are mathematical formulas, chemical formulas, tables, etc.▼ or ▲There are mathematical formulas, chemical formulas, tables, etc.▼, and R'R^1, R_
2 and R_3 have the same meanings as above), and then hydrolyze this compound to obtain a corresponding compound in which R' of the group Z' in the above general formula [I'] is hydrogen. 2-phenyl-4H-1,3
- A method for producing a thiazine derivative.
JP2543977A 1977-03-10 1977-03-10 2-phenyl-4H-1,3-thiazine derivative and method for producing the same Expired JPS6049635B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2543977A JPS6049635B2 (en) 1977-03-10 1977-03-10 2-phenyl-4H-1,3-thiazine derivative and method for producing the same

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2543977A JPS6049635B2 (en) 1977-03-10 1977-03-10 2-phenyl-4H-1,3-thiazine derivative and method for producing the same

Publications (2)

Publication Number Publication Date
JPS53111080A JPS53111080A (en) 1978-09-28
JPS6049635B2 true JPS6049635B2 (en) 1985-11-02

Family

ID=12166019

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2543977A Expired JPS6049635B2 (en) 1977-03-10 1977-03-10 2-phenyl-4H-1,3-thiazine derivative and method for producing the same

Country Status (1)

Country Link
JP (1) JPS6049635B2 (en)

Also Published As

Publication number Publication date
JPS53111080A (en) 1978-09-28

Similar Documents

Publication Publication Date Title
JPH01211567A (en) Novel sulfonamide compound
CA2368815A1 (en) Novel synthesis and crystallization of piperazine ring-containing compounds
US4578467A (en) Process for the preparation of 1-pyridyl-alkyl-4-aryl piperazines which are useful as antihypertensive compounds, their separation into the respective optical antipodes, and the stereoisomeric compounds so obtained
JPS63310882A (en) Polyoxygenated labdane derivative and manufacture
KR0163441B1 (en) Tricyclic(6.5.5)/(6,6,5)-fused oxazolidinone antibacterial agents
AU9707398A (en) Substituted heterocyclic benzocycloalkenes and the use thereof as substances having an analgesic effect
JPS6049635B2 (en) 2-phenyl-4H-1,3-thiazine derivative and method for producing the same
US6545149B2 (en) Synthesis and crystallization of piperazine ring-containing compounds
KR960012371B1 (en) New 5-methoxy alkyl ammonium tetrahydrofurans
UA79248C2 (en) Mandelate salts of substituted tetracyclic tetrahydrofuran derivatives
JPS62277392A (en) Sulfenamide derivative and production thereof
KR880001738B1 (en) Process for the preparation of imidazo(1,2-a)quinoline derivatives
JPH0256478A (en) 2, 3, 4, 5-tetrahydro-1-benzoxepine-3, 5-dione derivative and production thereof
JPH0631228B2 (en) Novel 5- (ω-ammonioacyloxymethylene) tetrahydrofurans and tetrahydrothiophenes, their production method and anti-PAF agent containing them
JPS6368568A (en) P-aminophenol derivative
EP0015786B1 (en) Imidazo and pyrimido-pyrido indoles, their preparation and medicines containing them
SU858565A3 (en) Method of preparing 1,3-perhydrothiazine derivatives
Highet et al. Dihydrotazettine methine, an unusual non-coplanar phenylcyclohexene
SAIGA et al. Synthesis of 1, 2, 3, 4-tetrahydro-β-carboline derivatives as hepatoprotective agents. IV. Positional isomers of 1, 2, 3, 4-tetrahydro-2-methylthiothiocarbonyl-β-carboline-3-carboxylic acid and its 1-alkylated derivatives
FR2785903A1 (en) 1-AMINOETHYLQUINOLEINE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC USE
JPH0522712B2 (en)
KR850000427B1 (en) Process for preparing pyrrole derivatives
US20040176591A1 (en) Novel synthesis and crystallization of peperazine ring-containing compounds
JPH1129471A (en) Medicine containing cumarin-derivative as active ingredient for liver disease
KR800000058B1 (en) Process for preparing benzocycloheptathiphene derivatives